![](/img/cover-not-exists.png)
Evaluation of 0.2 µg/day fluocinolone acetonide (ILUVIEN) implant in a cohort of previously treated patients with diabetic macular oedema (DMO): a 36-month follow-up clinical case series
Ahmed, Muna, Putri, Christine, Quhill, Hibba, Quhill, FahdVolume:
5
Journal:
BMJ Open Ophthalmology
DOI:
10.1136/bmjophth-2020-000484
Date:
July, 2020
File:
PDF, 1.26 MB
2020